Friday, August 8, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Financial Performance of Jasper Therapeutics for the Year Ending December 31 2023

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Biotechnology Markets and money
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Jasper Therapeutics recorded a net loss of $16.6 million and $64.5 million for the three months and the year ended on December 31, 2023, respectively. The basic and diluted net loss per share for common stockholders were $1.50 and $6.18 during the same periods. The company’s cash and cash equivalents totaled $86.9 million as of December 31, 2023. Research and development expenses for the year ended December 31, 2023, amounted to $51.8 million, with stock-based compensation expenses of $1.6 million included. General and administrative expenses for the same period were $17.1 million, with stock-based compensation expenses of $3.6 million.

—

On March 4, 2024, Jasper Therapeutics reported a net loss of $16.6 million and $64.5 million for the three months and the year ending on December 31, 2023. The basic and diluted net loss per share attributable to common stockholders were $1.50 and $6.18 for the same periods. Moreover, the company’s cash and cash equivalents as of December 31, 2023, were reported at $86.9 million. Research and development expenses for the year ending December 31, 2023, were $51.8 million, which included stock-based compensation expenses of $1.6 million. General and administrative expenses for the same period were $17.1 million, with stock-based compensation expenses of $3.6 million.

[bs_slider_forecast ticker=”JSPR”]

JSPR Stock Shows Strong Performance with Positive Price Momentum in Pre-Market Trading

On March 4, 2024, JSPR stock had a strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. This indicates positive price momentum for the stock. The price of JSPR shares had increased by $0.83 since the market last closed, representing a 3.91% rise. In pre-market trading on March 4, the stock had risen by an additional $0.67. This strong performance suggests that investors have confidence in JSPR and are optimistic about its future prospects. It is important for investors to continue monitoring JSPR stock and staying informed about any news or developments that may impact its performance.

Currently Playing

JSPR Stock Performance Review: Mixed Data Leaves Investors Uncertain on March 4, 2024

On March 4, 2024, investors in JSPR stock may have been feeling uncertain about the company’s financial performance based on the available data. According to CNN Money, JSPR’s total revenue information was currently unavailable, leaving investors without a key indicator of the company’s financial health.

The data that was available showed that JSPR had experienced a decrease in net income over the past year. The company reported a net income of -$37.69 million for the past year, which was a 23.0% decrease from the previous year. In the most recent quarter, JSPR reported a net income of -$17.54 million, representing a 9.1% decrease from the previous quarter.

Despite the decrease in net income, there was a glimmer of hope for investors in the form of earnings per share (EPS) data. JSPR reported an EPS of -$10.33 for the past year, which actually represented a 61.59% increase from the previous year. However, in the most recent quarter, the company reported an EPS of -$1.60, which was an 8.61% decrease from the previous quarter.

Overall, the mixed performance data for JSPR on March 4, 2024, may have left investors feeling uncertain about the company’s future prospects. While the increase in EPS over the past year was a positive sign, the decreases in net income over the same period could be cause for concern. Without more information on the company’s total revenue, investors may have been left wondering about JSPR’s overall financial health and future performance.

[stock_market_chart symbol=”JSPR” range=”3mo” interval=”1d” settings='{“primaryChartType”:”smoothedLine”,”secondaryChartType”:”column”,”width”:”100%”,”height”:”500px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:14,”color”:”#383838″,”primaryLineColor”:”#5679ff”,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#5679ff”,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#020202″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#e8e8e8″,”scrollbarSelectedBackgroundColor”:”#f7f7f7″,”scrollbarGraphFillColor”:”#435dc2″,”scrollbarSelectedGraphFillColor”:”#92a8fc”,”primaryLineThickness”:2,”secondaryLineThickness”:1,”gridThickness”:1,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”searchMode”:”search”,”mouseWheelZoomEnabled”:false,”cursorEnabled”:true,”exportEnabled”:true,”scrollbarEnabled”:true,”legendEnabled”:true,”periods”:”1D,1M,YTD,ALL”,”defaultPeriod”:”1M”}’]

Tags: JSPR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ projections

Financial Analysts Bullish on Li Auto Stock

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Lyfts Stock Rises After Upgrade from RBC Capital

Pharmaceutical Markets and money

Analyst Raghuram Selvaraju Reiterates Buy Rating for BridgeBio Pharma with 47 Price Target

Recommended

ALB stock news

Allspring Global Investments Increases Stake in Automotive Parts Company, Douglas Dynamics Inc.

2 years ago
Technology Robotics Markets and money

Exela Technologies Inc and XBP Europe Launch Reaktrai Revolutionizing Cybersecurity and Data Management with AI

2 years ago

Positive Outlook and Increased Price Target for Corteva

2 years ago
Alternative Energy Markets and money (1)

Ecopetrols Commitment to Thorough Evaluation and Reliable Results for Arauca 8 Well

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DLTR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

Lucid Group Stock: Turbulence Amid Policy Shifts and Uber Deal

Walt Disney Stock: Marvel Woes Offset by NFL Deal

Fresenius Stock: Mixed Q2 Results Amid Margin Pressures

Beiersdorf Stock: Nivea’s Glow Fades as Forecasts Dim

ABN Amro Stock: Profit Dip Amid Strong Capital Moves

Vonovia Stock: Strong Recovery Fuels Optimism

Trending

Snap Stock
Stocks

Snap Stock: Turmoil Amid Advertising Woes

by Dieter Jaworski
August 6, 2025
0

Snap Inc.'s stock has become a battleground for Wall Street analysts following disappointing Q2 results, with price...

DHL Stock

DHL Stock: Rollercoaster Ride Amid Strong Earnings

August 6, 2025
Klöckner Stock

Klöckner Stock: Turnaround Amid Market Volatility

August 6, 2025
Lucid Group Stock

Lucid Group Stock: Turbulence Amid Policy Shifts and Uber Deal

August 6, 2025
Walt Disney Stock

Walt Disney Stock: Marvel Woes Offset by NFL Deal

August 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Gilead Sciences Stock: HIV Breakthrough Fuels Rally August 8, 2025
  • Apple Stock: Surges on Tariff Exemption and $600B US Pledge August 8, 2025
  • Yandex Stock: Cloud Specialist Nebius Soars on Record Growth August 7, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com